Previously we have shown that rLm30, expressing the r30/Ag85B downstream of the Lm actA promoter and ligated to the N-terminal 100 amino acids of ActA (ActAN) as a fusion protein, boosts BCG-primed efficacy against TB (22). This evidence concerns the gene ACTA1 and tuberculosis.